# A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma

> **NCT00683761** · PHASE1,PHASE2 · UNKNOWN · sponsor: **TransMolecular** · enrollment: 64 (estimated)

## Conditions studied

- Malignant Glioma
- Glioblastoma Multiforme
- GBM
- Astrocytoma
- Oligodendroglioma

## Interventions

- **DRUG:** 131I-TM601

## Key facts

- **NCT ID:** NCT00683761
- **Lead sponsor:** TransMolecular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2010-02
- **Final completion:** 2010-04
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2009-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683761, "A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00683761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*